2021 New Mexico Statutes
Article 1 - General Provisions
Section 26-1-21 - Power of board to publish reports and disseminate information.

A. The board may cause to be published from time to time reports summarizing all judgments, decrees and court orders which have been rendered, including the nature of the charge and the disposition thereof.
B. The board may also cause to be disseminated such information regarding drugs, devices and cosmetics as the board deems necessary in the interest of the public health and the protection of the consumer against fraud. Nothing in this section shall be construed to prohibit the board from collecting, reporting and illustrating the results of the investigations of the board.
History: 1953 Comp., § 54-6-46, enacted by Laws 1967, ch. 23, § 21.
Generally. — A statute such as this one authorizes or permits the pharmacy board to make public, through the pharmaceutical association drug store "El Boticario," an item pertaining to the sale of a legendary drug to a nondrug store, if a conviction or convictions have been obtained in the courts of the state of New Mexico, but not otherwise. 1953 Op. Att'y Gen. No. 53-5865 (opinion rendered under former law).
The board is permitted and authorized to disseminate all reports and other information, and the fact that the firms, persons or agencies named in said item are published in an outside publication would not incriminate the board or agency mentioned in all cases where conviction or convictions have been obtained in the courts of this state, but not otherwise. 1953 Op. Att'y Gen. No. 53-5865 (opinion rendered under former law).

Structure 2021 New Mexico Statutes

2021 New Mexico Statutes

Chapter 26 - Drugs and Cosmetics

Article 1 - General Provisions

Section 26-1-1 - Short title.

Section 26-1-2 - Definitions.

Section 26-1-3 - Prohibited acts.

Section 26-1-3.1 - Repealed.

Section 26-1-3.2 - Prescription drug donation.

Section 26-1-4 - Power to enjoin violations.

Section 26-1-5 - Penalty; exemptions.

Section 26-1-6 - Detection of drugs, devices or cosmetic believed adulterated, misbranded or counterfeit; condemnation; destruction or correction of defect; forfeiture and sale.

Section 26-1-7 - Attorney general or district attorney to institute prosecutions.

Section 26-1-8 - Minor violations of act; warnings authorized.

Section 26-1-9 - Addition of poisonous or deleterious substances; color additives.

Section 26-1-10 - Drug or device adulteration.

Section 26-1-11 - Drug or device; misbranding.

Section 26-1-12 - False advertising.

Section 26-1-13 - Packaging and labeling requirements; proprietary preparations.

Section 26-1-14 - New drugs and devices; prerequisites to sale, delivery or giving away; exceptions.

Section 26-1-15 - Dangerous drugs; veterinary use; limitations.

Section 26-1-16 - Dangerous drugs; conditions for sale; prescription refilling; limitations.

Section 26-1-16.1 - Opioids; requiring practitioners to obtain and review reports from the prescription monitoring program.

Section 26-1-17 - Testing laboratory.

Section 26-1-18 - Promulgating regulations; procedure.

Section 26-1-18.1 - Prescription drug prior authorization protocols.

Section 26-1-19 - Power to make inspections and secure samples.

Section 26-1-20 - Personnel.

Section 26-1-21 - Power of board to publish reports and disseminate information.

Section 26-1-22 - Unlawful means of obtaining dangerous drugs enumerated.

Section 26-1-23 - False statements; false pretenses; forgery of labels or prescriptions prohibited.

Section 26-1-24 - Cosmetics; misbranding.

Section 26-1-25 - Cosmetics; adulteration.

Section 26-1-26 - Penalties.